Nathan Fastman

Nathan Fastman has a diverse work experience in scientific research. From 2019 to the present, they have worked at Maze Therapeutics, starting as a Scientist I and progressing to Scientist II. Currently, they hold the position of Senior Scientist. At Maze Therapeutics, they have contributed to various projects involving therapeutic research.

Prior to their time at Maze Therapeutics, Nathan worked as a PhD candidate at Stanford University School of Medicine from 2013 to 2019. During their tenure, they focused on the structure and mechanism of SWEET family transporters and successfully determined crystal structures of a glucose transporter, leading to a better understanding of its transport mechanism.

Before pursuing their PhD, Nathan gained research experience as an undergraduate student at the University of Maryland Baltimore County. In the field of organic chemistry, they performed organic syntheses, purified small molecule products, and determined their structures using various techniques. Additionally, they assessed the activity of the Hepatitis C viral helicase. As an undergraduate biology researcher, Nathan characterized the expression and localization of certain proteins.

Nathan also had a brief research experience as an undergraduate student at Johns Hopkins Bloomberg School of Public Health, where they verified anti-malarial mosquito genes and measured bacterial colonization in mosquito midguts.

Overall, Nathan Fastman's work experience demonstrates their expertise and dedication in the field of scientific research, particularly in therapeutic development, protein structure determination, organic chemistry, and molecular microbiology.

Nathan Fastman completed their PhD in Biophysics from Stanford University in 2019. Prior to that, they obtained a BS degree in Biochemistry from the University of Maryland Baltimore County in 2013.